At the tumor microenvironment level, treatments with AgNPs-G and doxorubicin significantly increased (p ≤ 0.05) the levels of TNF-α, IFN-γ, and IL-6 compared to the control group (Figure 4). This evidence concerns the gene TNF and neoplasm.